Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: Preparation, optimization, in vitro/in vivo evaluation

Abdelbary, 2011, Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes, Pharm. Dev. Technol., 16, 44, 10.3109/10837450903479988 Abu-Rizq, 2008, Cyto-protective and immunomodulating effect of Curcuma longa in Wistar rats subjected to carbon tetrachloride-induced oxidative stress, Inflammopharmacology, 16, 87, 10.1007/s10787-007-1621-1 Alsarra, 2005, Proniosomes as a drug carrier for transdermal delivery of ketorolac, Eur. J. Pharm. Biopharm., 59, 485, 10.1016/j.ejpb.2004.09.006 Alves, 2004, Phospholipid dry powders produced by spray drying processing: structural, thermodynamic and physical properties, Powder Technol., 145, 139, 10.1016/j.powtec.2004.06.008 Aranya, 2003, Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol, Colloids Surf. B: Biointerfaces, 30, 129, 10.1016/S0927-7765(03)00080-8 Balakrishnan, 2009, Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery, Int. J. Pharm., 377, 1, 10.1016/j.ijpharm.2009.04.020 Bancroft, 1996 Betageri, 1994, Liposomes as drug carriers, Pharm. Eng., 14, 76 Chi, 2003, A polymeric micellar carrier for the solubilization of biphenyl dimethyl dicarboxylate, Arch. Pharm. Res., 26, 173, 10.1007/BF02976666 Dash, 2002, X-ray powder diffractometric method for quantitation of crystalline drug in microparticulate systems. I: Microspheres, J. Pharm. Sci., 91, 983, 10.1002/jps.10090 Du Plessis, 1996, The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage, Int. J. Pharm., 127, 273, 10.1016/0378-5173(95)04281-4 Fotaki, 2010, Biorelevant dissolution methods and their applications in in vitro–in vivo correlations for oral formulations, Open Drug Deliv. J., 4, 2, 10.2174/1874126601004020002 Frfkjaer, 1984, Stability testing of liposomes during storage, vol. 1, 235 Gupta, 2007, Proniosomal powder of captopril: formulation and evaluation, Mol. Pharm., 4, 596, 10.1021/mp0700110 Hancock, 1997, Characteristics and significance of the amorphous state in pharmaceutical systems, J. Pharm. Sci., 86, 1, 10.1021/js9601896 Hao, 2002, Studies on a high encapsulation of colchicine by a niosome system, Int. J. Pharm., 244, 73, 10.1016/S0378-5173(02)00301-0 Hiremath, 2009, Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine, Int. J. Pharm., 380, 96, 10.1016/j.ijpharm.2009.07.008 Hu, 2000, Proniosomes: a novel drug carrier preparation, Int. J. Pharm., 206, 110, 10.1016/S0378-5173(00)00513-5 Jarmer, 2005, Supercritical fluid crystallization of griseofulvin crystal habit modification with a selective growth inhibitor, J. Pharm. Sci., 94, 2688, 10.1002/jps.20463 Jose, 2000, Hepatoprotective activity of Emblica officinalis and Chyavanaprash, J. Ethnopharmacol., 72, 135, 10.1016/S0378-8741(00)00219-1 Kim, 2001, Preparation and evaluation of biphenyl dimethyl dicarboxylate microemulsions for oral delivery, J. Control. Release, 70, 149, 10.1016/S0168-3659(00)00343-6 Mokhtar, 2008, Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes, Int. J. Pharm., 361, 104, 10.1016/j.ijpharm.2008.05.031 Moon, 1999, Enhanced dissolution and permeation of biphenyl dimethyl dicarboxylate using solid dispersions, J. Kor. Pharm. Sci., 29, 227 Moore, 1996, Mathematical comparison of dissolution profiles, Pharm. Technol., 20, 64 Moribe, 1999, Encapsulation characteristics of nystatin in liposomes: effects of cholesterol and polyethylene glycol derivatives, Int. J. Pharm., 188, 193, 10.1016/S0378-5173(99)00222-7 Moribe, 1999, Molecular localization and state of Amphotericin B in PEG liposomes, Int. J. Pharm., 193, 97, 10.1016/S0378-5173(99)00323-3 Najmi, 2005, Free radical scavenging and hepatoprotective activity of jigrine against galactosamine induced hepatopathy in rats, J. Ethnopharmacol., 97, 521, 10.1016/j.jep.2004.12.016 Nasr, 2010, In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration, AAPS PharmSciTech, 11, 85, 10.1208/s12249-009-9364-5 Nasr, 2008, Vesicular aceclofenac systems: a comparative study between liposomes and niosomes, J. Microencapsul., 25, 499, 10.1080/02652040802055411 Ning, 2005, Preparation and evaluation of proliposomes containing clotrimazole, Chem. Pharm. Bull., 53, 620, 10.1248/cpb.53.620 Pereira-Lachataignerais, 2006, Study and formation of vesicle systems with low polydispersity index by ultrasound method, Chem. Phys. Lipids, 140, 88, 10.1016/j.chemphyslip.2006.01.008 Semalty, 2009, Development and physicochemical evaluation of pharmacosomes of diclofenac, Acta. Pharm., 59, 335, 10.2478/v10007-009-0023-x Shah, 2008, Comparative evaluation of flow for pharmaceutical powders and granules, AAPS PharmSciTech, 9, 250, 10.1208/s12249-008-9046-8 Uchegbua, 1998, Non-ionic surfactant based vesicles (niosomes) in drug delivery, Int. J. Pharm., 172, 33, 10.1016/S0378-5173(98)00169-0 Wang, 2008, Diphenyl dimethyl bicarboxylate in the treatment of viral hepatitis, adjuvant or curative?, Gastroenterol. Res., 1, 2 Wong, 1982, Aggregation of dipalmitoylphosphotidylcholine vesicles, Biochemistry, 21, 4133, 10.1021/bi00260a033 Xiao, 2006, Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs, Int. J. Pharm., 319, 162, 10.1016/j.ijpharm.2006.03.037 Xu, 2009, Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits, J. Control. Release, 140, 61, 10.1016/j.jconrel.2009.07.014 Yang, 2007, Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation, Int. J. Pharm., 338, 317, 10.1016/j.ijpharm.2007.02.011 Zeisig, 1996, Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines, Biochim. Biophys. Acta Biomembr., 1285, 237, 10.1016/S0005-2736(96)00167-8 Zhipeng, 2010, Distribution of liposomal bifendate in liver following intravenous injection in mice, J. Drug Target., 18, 627, 10.3109/10611861003639788 Zidan, 2011, Multivariate optimization of formulation variables influencing flurbiprofen proniosomes characteristics, J. Pharm. Sci., 100, 2212, 10.1002/jps.22453